SCHEMBL10699652

SCHEMBL10699652

CCCCCN1C(=O)C(C)(C)c2cc(NC(=O)c3cccs3)c([N+](=O)[O-])cc21

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.49
RAB9A P51151 3/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
MAPT P10636 8/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C9 P11712 1/20 0.47
L3MBTL1 Q9Y468 2/20 0.45
MEN1 O00255 5/20 0.43
KMT2A Q03164 5/20 0.43
ALDH1A1 P00352 3/20 0.41
LMNA P02545 3/20 0.41
HTT P42858 2/20 0.41
MITF O75030 1/20 0.39
POLB P06746 1/20 0.39
GAA P10253 1/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10696515 0.97 NPC1 (0.50) NPC1RAB9ASMN1; SMN2MAPTCYP1A2
SCHEMBL10698900 0.94 NPC1 (0.52) NPC1RAB9ASMN1; SMN2MAPTCYP1A2
SCHEMBL10717276 0.90 NPC1 (0.53) NPC1RAB9ASMN1; SMN2MAPTCYP1A2
SCHEMBL10698508 0.85 MAPT (0.53) NPC1RAB9ASMN1; SMN2MAPTCYP1A2
SCHEMBL10698960 0.84 MAPT (0.41) NPC1RAB9ASMN1; SMN2MAPTCYP1A2
SCHEMBL10697121 0.84 MEN1 (0.49) SMN1; SMN2MAPTL3MBTL1MEN1KMT2A
SCHEMBL10697763 0.83 ALDH1A1 (0.34) NPC1RAB9ASMN1; SMN2MAPTCYP1A2
SCHEMBL10696939 0.83 SMN1; SMN2 (0.49) NPC1RAB9ASMN1; SMN2MAPTCYP2C9
SCHEMBL10697943 0.81 MAPT (0.41) NPC1RAB9ASMN1; SMN2MAPTCYP1A2
SCHEMBL10701527 0.81 MAPT (0.49) NPC1SMN1; SMN2MAPTCYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0268178-A1 Pyrrolo-benzimidazoles, medicaments containing these compounds and process for their preparation Dr. Karl Thomae GmbH (DE) 1988-05-25 EP disclosed